University of Crete (UOC)
Μελέτη του ρόλου των συνδεκανών στην παθογένεια του ινοσαρκώματος και διερεύνηση της επίδρασης των αυξητικών παραγόντων
Abstract
dc:descriptionThe focus of the present PhD thesis was to further understand the underlyingmechanisms that are responsible for the progress of human adult fibrosarcoma. Withthe utilization of new, specialized techniques, which have resulted in newclassification systems it is defined as a rare tumor with poor prognosis. This softtissue sarcoma is derived from the malignant transformation of the fibroblasts, cellsknown to produce abundant extracellular matrix (ECM) which ultimately supportssurrounding tissues. Fibrosarcoma cells are morphologically characterized asspindle cells, with enhanced motility.It is well established that fibrosarcoma cells strongly modulate thesurrounding ECM. ECM is a complex extracellular network containingproteoglycans, fibrous proteins and hyaluronic acid, which supports and protectsthe cells within the tissues. Moreover, ECM is able to create and transfer multiplesignals to the cells, thus affecting their basic functions and behaviour. Indeed, ECMis a pool of growth factors, such as TGF (transforming growth factor), EGF(epidermal growth factor), FGF (fibroblast growth factor), VEGF (vascularendothelial growth factor), IGF-Ι (insulin-like growth factor), enzymes like theMMPs (matrix metalloproteinases), synthases, transferases, sulfases and a wholegroup of other interesting macromolecules which can affect cell behaviour.Proteoglycans are molecules composed of glycosaminoglycan chains (GAG),covalently attached to their protein core. They are classified according to their GAGchains into separate groups: KSPGs (keratan sulfate proteoglycans), HSPGs (heparansulfate proteoglycans), CSPGs (chondroitin sulfate proteoglycans) and DSPGs(dermatan sulfate proteoglycans). They possess the ability to affect cell functions andultimately the evolution of a tumour with various mechanisms. Τheir complexfunctionality comes not only from their basic morphology, but also from their finalstereotactic modification by specialized enzymes. These alterations can induceimportant changes like different localization, degradation and recycling, interplaywith other factors, let alone different signalling, both outwards and inwards of thecell. One of the unique proteoglycan characteristics is the direct contact with theECM and the consequent transport of environmental signals towards the inner partof the cells.Syndecan 2 (SDC2), a heparan sulfate proteoglycan, is known to be crucial forthe proliferation and migration of human fibrosarcoma cells (HT1080). SDC2 isrecognized to modify the actin cytoskeleton and consequently alter HT1080 cellmigration through the FAK/PI3K/Rac signalling pathway.One of the well-studied growth factors, proven to affect the progress offibrosarcoma, is TGFβ2. It has been reported that TGFβ2 can control the formation ofECM and subsequently, the invasiveness and migration of HT1080 cells.In this study, we show the ability of TGFβ2 to enhance the adhesion ofHT1080 cells towards fibronectin (FN) (p ≤ 0.01). Adhesion of cells to other cells aswell as the ECM is known to affect the invasive abilities of the cells. SDC2 seems tobe essential when it comes to TGFβ2-induced HT1080 cell adhesion, as this ability isremarkably down-regulated in SDC2-deficient cells (p ≤ 0.01).We also show that SDC2 is important for Smad2 activation, an indispensablemediator of TGFβ signalling. It seems that TGFβ2-dependent Smad2phosphorylation is significantly decreased in HT1080 cells that lack SDC2 (P ≤ 0.05).The co-localization and the regulation of the expression of TGFRIII, one of theTGFβ receptors, is another interesting quality of SDC2. In our study, we confirm theimportance of SDC2 in the regulation of TGFRIII expression (p ≤ 0.01) and suggestthat this proteoglycan participates in the presentation of TGFRIII on the cellmembrane.We also showed that SDC2 modulates the TGF-dependent expression (p ≤0.05) and activation (p ≤ 0.01) of FAK, as well as of integrin β1 (p ≤ 0.01), two genesthat are necessary for cell adhesion towards FN.Additionally, we studied the effect of HS chains on human fibrosarcoma cellfunctions. It is already known that HS chains can influence TGFβ-induced cellmotility. In order to proceed with these experiments, we used heparitinase, toachieve the specialized digestion of HS chains. This resulted in the formation of HSstubs. Interestingly, the otherwise TGFβ2-enhanced HT1080 cell adhesion wascompletely reversed after the addition of heparitinase and the shedding of HS chains(p ≤ 0.001). This outcome highlights the important role of HS chains on TGFβ2-induced cell adhesion.Furthermore, HS shedding inhibited TGFβ2-dependent Smad2 activation (p ≤0.001). The consequent down-regulation of the TGFβ2 signalling pathway explainsthe inhibitory effect of HS chains on ΤGFβ2-promoted HT1080 cell adhesion.Finally, the present PhD thesis studied the potential role of IGF-I infibrosarcoma progression. IGF-I is a known anabolic hormone, with provenoncogenic behaviour. Most of the downstream signalling is conducted through twomain signalling pathways: PI3K/AKT and MEK/ERK.While examining the effect of IGF-I on HT1080 cells, we reported aremarkable increase in cell migration, when cells were treated with IGF-I (p ≤ 0.001).SDC2 is abundant in fibrosarcoma and, as previously mentioned, SDC2 can regulatecell motility by changing actin cytoskeleton. Taking into account its unique abilities,we examined its possible participation in IGF-I pathways. The silencing of SDC2gene resulted interestingly in the inhibition of IGF-I induced HT1080 cell migration(p ≤ 0.001).Knowing that SDC2 can play the role of the co-receptor for several growthfactors, such as FGF and GM-CSF (granulocyte-macrophage colony-stimulatingfactor), the next step was to examine whether SDC2 could be a co-receptor for IGF-Itoo. In the present study, we show for the first time that SDC2 is co-localized withIGF-IR, suggesting that SDC2 could be a co-receptor for IGF-I and subsequentlyaffect its bioavailability and downstream signalling.Next, we examined the participation of SDC2 in IGF-I signalling and cellmigration. As ERK1/2 is an important mediator of IGF-I signalling and affects cellmotility in various types of cancer, we tested the effect of SDC2 in IGF-I inducedERK1/2 activation. We show that SDC2 is essential for ERK1/2 phosphorylation (p ≤0.001) and we also show that ERK1/2 is essential for the IGF-I dependent HT1080cell migration (p ≤ 0.001). This could mean that SDC2 regulates IGF-Ι inducedmigration, at least partly through ERK1/2 activation and via the subsequentERK1/2-dependent gene transcription towards specific cell behaviours.Finally, we examined the putative role of ezrin, a protein-linker betweenreceptors of the cell membrane and actin cytoskeleton. It has been previously foundto be co-localized with SDC2 in filopodia of fibroblast-like cells. Interestingly, weshowed for the first time in our cells, that adding IGF-I to HT1080 cells leads toactivation of ezrin (p ≤ 0.001) and we confirmed that ezrin is co-localized with SDC2in ΗΤ1080 cells, making their lamellipodia more prominent. With these results, wepresent some of the mechanisms through which SDC2 participates in IGF-IdependentHT1080 cell migration.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mytilinaiou, Maria
- Μυτιληναίου, Μαρία
Subjects
dc:subject × 16- Συνδεκάνες
- Αυξητικός παράγοντας μετασχηματισμού-Β (TGFβ2)
- Ινσουλινοειδής αυξητικός παράγοντας-1 (IGF-1)
- Ινοσάρκωμα
- Κυτταρική προσκόλληση
- Κυτταρική μετανάστευση
- Syndecans
- TGFβ2
- IGF1
- Fibrosarcoma
- Cell adhesion
- Cell migration
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43615